{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:26:48Z","timestamp":1790324808759,"version":"4.1.0"},"reference-count":60,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"abstract":"<jats:p>ABSTRACT Neuropsychiatric disorders are common among patients with Parkinson\u2019s disease and may appear in any stage of the disease. However, these disorders often go undiagnosed and receive insufficient treatment. Observations in recent years have revealed that dopamine replacement therapy may lead to the development or worsening of conditions, such as gambling disorder, compulsive sexual behavior, compulsive buying and binge eating, in addition to punding and dopamine dysregulation syndrome. The pathophysiology of these disorders seems to be related to abnormal dopaminergic stimulation of the basal regions of the basal ganglia, especially via nigro-mesolimbic pathways. The aim of the present study was to perform a literature review on impulsivity, impulse control disorders and related conditions among patients with Parkinson\u2019s disease, with emphasis on their epidemiology, clinical characteristics and treatment.<\/jats:p>","DOI":"10.1590\/0004-282x20180052","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T19:52:49Z","timestamp":1530993169000},"page":"399-410","source":"Crossref","is-referenced-by-count":21,"title":["Impulse control and related disorders in Parkinson\u2019s disease"],"prefix":"10.1590","volume":"76","author":[{"given":"Antonio Pedro","family":"Vargas","sequence":"first","affiliation":[{"name":"Rede SARAH de Hospitais de Reabilita\u00e7\u00e3o, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Eduardo Costa","family":"Cardoso","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2018,6]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/PL00005481","article-title":"Varieties of impulsivity","volume":"146","author":"Evenden JL","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2011.00001","article-title":"Impulse control disorders: updated review of clinical characteristics and pharmacological management","volume":"2","author":"Schreiber L","year":"2011","journal-title":"Front Psychiatry"},{"key":"ref3","article-title":"Dopamine signaling in reward-related behaviors","volume":"7","author":"Baik JH","year":"2013","journal-title":"Front Neural Circuits"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.psychres.2011.04.006","article-title":"Impulse control disorders in psychiatric inpatients","volume":"188","author":"M\u00fcller A","year":"2011","journal-title":"Psychiatry Res"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/nyas.13356","article-title":"Gambling disorder: an integrative review of animal and human studies","volume":"1394","author":"Nautiyal KM","year":"2017","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.comppsych.2013.12.003","article-title":"Impulse control disorders in elderly patients","volume":"55","author":"Tamam L","year":"2014","journal-title":"Compr Psychiatry"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/cen.12375","article-title":"Impulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case-control study","volume":"80","author":"Bancos I","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"ref8","first-page":"81","article-title":"Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study","volume":"33","author":"Cornelius JR","year":"2010","journal-title":"Sleep"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/bs.irn.2017.04.006","article-title":"Impulse control and related disorders in Parkinson\u2019s disease","volume":"133","author":"Weintraub D","year":"2017","journal-title":"Int Rev Neurobiol"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1474-4422(17)30004-2","article-title":"Impulse control disorders and levodopa-induced dyskinesias in Parkinson\u2019s disease: an update","volume":"16","author":"Voon V","year":"2017","journal-title":"Lancet Neurol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jns.2016.07.003","article-title":"The high prevalence of impulse control behaviors in patients with early-onset Parkinson\u2019s disease: A cross-sectional multicenter study","volume":"368","author":"Vela L","year":"2016","journal-title":"J Neurol Sci"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1212\/WNL.0b013e31827b915c","article-title":"Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study","volume":"80","author":"Weintraub D","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/mds.23501","article-title":"Impulsivity and compulsivity in drug-na\u00efve patients with Parkinson\u2019s disease","volume":"26","author":"Antonini A","year":"2011","journal-title":"Mov Disord"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub D","year":"2010","journal-title":"Arch Neurol"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/jnnp-2016-315277","article-title":"ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson\u2019s disease","volume":"88","author":"Antonini A","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.parkreldis.2009.12.002","article-title":"Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease","volume":"16","author":"Lee JY","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/157488612800492726","article-title":"Impulsive and compulsive behaviors during dopamine replacement treatment in Parkinson\u2019s Disease and other disorders","volume":"7","author":"Raja M","year":"2012","journal-title":"Curr Drug Saf"},{"issue":"4","key":"ref18","first-page":"231","article-title":"Clinical and psychopathological factors associated with impulse control disorders in Parkinson\u2019s disease","volume":"31","author":"S\u00e1ez-Franc\u00e0s N","year":"2016","journal-title":"Neurolog\u00eda"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jnnp-2013-306787","article-title":"Impulse control disorder in patients with Parkinson\u2019s disease under dopamine agonist therapy: a multicentre study","volume":"85","author":"Garcia-Ruiz PJ","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/WNF.0b013e31826e6e6d","article-title":"Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease","volume":"35","author":"Perez-Lloret S","year":"2012","journal-title":"Clin Neuropharmacol"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/mds.23845","article-title":"Hypersexuality and pathological gambling in Parkinson\u2019s disease: A cross-sectional case-control study","volume":"26","author":"de Chazeron I","year":"2011","journal-title":"Mov Disord"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/JCP.0b013e3182979830","article-title":"A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs","volume":"33","author":"Poletti M","year":"2013","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.parkreldis.2011.09.007","article-title":"Impulse control disorders and depression in Finnish patients with Parkinson\u2019s disease","volume":"18","author":"Joutsa J","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.parkreldis.2013.09.006","article-title":"Impulsive and compulsive behaviors among Danish patients with Parkinson\u2019s disease: prevalence, depression, and personality","volume":"20","author":"Callesen MB","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2009.06.074","article-title":"Impulse control disorders in Parkinson\u2019s disease in a Chinese population","volume":"465","author":"Fan W","year":"2009","journal-title":"Neurosci Lett"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-017-0874-6","article-title":"Clinical characteristics of impulse control and related disorders in Chinese Parkinson\u2019s disease patients","volume":"17","author":"Zhang Y","year":"2017","journal-title":"BMC Neurol"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.parkreldis.2011.06.001","article-title":"Impulse control disorders in Chinese Parkinson\u2019s disease patients: the effect of ergot derived dopamine agonist","volume":"17","author":"Auyeung M","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1468-1331.2011.03571.x","article-title":"Are there ethnic differences in impulsive\/compulsive behaviors in Parkinson\u2019s disease?","volume":"19","author":"Chiang HL","year":"2012","journal-title":"Eur J Neurol"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.parkreldis.2013.03.004","article-title":"Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson\u2019s disease","volume":"19","author":"Valen\u00e7a GT","year":"2013","journal-title":"Parkinsionism Relat Disord"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/WNF.0000000000000202","article-title":"A Multicenter comparative study of impulse control disorder in Latin American patients with Parkinson Disease","volume":"40","author":"Ram\u00edrez G\u00f3mez CC","year":"2017","journal-title":"Clin Neuropharmacol"},{"key":"ref31","first-page":"357","article-title":"Prevalencia de trastornos neuropsiquiatricos en pacientes con enfermedad de Parkinson (EP) no tratados","volume":"152","author":"Isaias-Millan S","year":"2016","journal-title":"Gac Med Mex"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.parkreldis.2014.05.014","article-title":"Impulse control and related disorders in Mexican Parkinson\u2019s disease patients","volume":"20","author":"Rodr\u00edguez-Violante M","year":"2014","journal-title":"Parkinsionism Relat Disord"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/ana.22356","article-title":"Impulse control disorders in Parkinson disease: a multicenter case: control study","volume":"69","author":"Voon V","year":"2011","journal-title":"Ann Neurol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/jnnp-2017-316576","article-title":"Sleep and REM behaviour disorder in Parkinson\u2019s disease with impulse controle disorder","volume":"89","author":"Fantini ML","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3233\/JPD-120165","article-title":"A systematic review of impulse control disorders in Parkinson\u2019s disease","volume":"3","author":"Callesen MB","year":"2013","journal-title":"J Parkinsons Dis"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/mds.21611","article-title":"Pathological gambling in Parkinson\u2019s disease: risk factors and differences from dopamine dysregulation: an analysis of published case series","volume":"22","author":"Gallagher DA","year":"2007","journal-title":"Mov Disord"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0269881106073109","article-title":"New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson\u2019s disease: the role of dopamine agonist treatment and age at motor symptoms onset","volume":"21","author":"Giladi N","year":"2007","journal-title":"J Psychopharmacol"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/ene.13078","article-title":"Impulse control disorder related behaviours during long-term rotigotine treatment: a post hoc analysis","volume":"23","author":"Antonini A","year":"2016","journal-title":"Eur J Neurol"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1080\/08870446.2016.1218879","article-title":"Impulse control disorders in Parkinson\u2019s disease: predominant role of psychological determinants","volume":"31","author":"Garlovsky JK","year":"2016","journal-title":"Psychol Health"},{"issue":"7","key":"ref40","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s10072-012-1224-5","article-title":"Neuropsychological features of patients with Parkinson\u2019s disease and impulse control disorders","volume":"34","author":"Bentivoglio AR","year":"2013","journal-title":"Neurol Sci"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/mds.26160","article-title":"Long-term cognitive follow-up of Parkinson\u2019s disease patients with impulse control disorders","volume":"30","author":"Siri C","year":"2015","journal-title":"Mov Disord"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.133","article-title":"Dopaminergic function and intertemporal choice","volume":"5","author":"Joutsa J","year":"2015","journal-title":"Transl Psychiatry"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00702-016-1648-9","article-title":"Impaired learning of punishments in Parkinson\u2019s disease with and without impulse control disorder","volume":"124","author":"Leplow B","year":"2017","journal-title":"J Neural Transm (Vienna)"},{"issue":"14","key":"ref44","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1212\/WNL.0000000000003177","article-title":"Impulsive-compulsive behaviors in parkin-associated Parkinson disease","volume":"87","author":"Morgante F","year":"2016","journal-title":"Neurology"},{"issue":"10","key":"ref45","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/jnnp-2015-312848","article-title":"Clinical-genetic model predicts incident impulse control disorders in Parkinson\u2019s disease","volume":"87","author":"Kraemmer J","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1586\/14737175.2016.1158103","article-title":"Treatment of impulse control disorders in Parkinson\u2019s disease: practical considerations and future directions","volume":"16","author":"Ramirez-Zamora A","year":"2016","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archneurol.2009.294","article-title":"Dopamine agonist withdrawal syndrome in Parkinson disease","volume":"67","author":"Rabinak CA","year":"2010","journal-title":"Arch Neurol"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s00415-016-8314-x","article-title":"Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease","volume":"264","author":"Merola A","year":"2017","journal-title":"J Neurol"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.22164","article-title":"Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study","volume":"68","author":"Weintraub D","year":"2010","journal-title":"Ann Neurol"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ana.22029","article-title":"Pathological gambling in Parkinson disease is reduced by amantadine","volume":"68","author":"Thomas A","year":"2010","journal-title":"Ann Neurol"},{"issue":"9","key":"ref51","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1212\/WNL.0b013e3182840678","article-title":"Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers","volume":"80","author":"Okai D","year":"2013","journal-title":"Neurology"},{"issue":"10","key":"ref52","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.parkreldis.2012.06.005","article-title":"Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson\u2019s disease","volume":"18","author":"Joutsa J","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"ref53","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.parkreldis.2010.02.006","article-title":"Long term follow-up of Parkinson\u2019s disease patients with impulse control disorders","volume":"16","author":"Sohtao\u011flu M","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"ref54","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/mds.23508","article-title":"The prevalence and clinical characteristics of punding in Parkinson\u2019s disease","volume":"26","author":"Spencer AH","year":"2011","journal-title":"Mov Disord"},{"issue":"4","key":"ref55","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00415-010-5817-8","article-title":"Management of punding in Parkinson\u2019s disease: an open-label prospective study","volume":"258","author":"Fasano A","year":"2011","journal-title":"J Neurol"},{"issue":"23","key":"ref56","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1212\/WNL.0000000000004012","article-title":"Role of habenula and amygdala dysfunction in Parkinson disease patients with punding","volume":"88","author":"Markovic V","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"ref57","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00702-013-1100-3","article-title":"Repetitive transcranial magnetic stimulation transiently reduces punding in Parkinson\u2019s disease: a preliminary study","volume":"121","author":"Nardone R","year":"2014","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"ref58","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jnnp-2012-303988","article-title":"Dopamine dysregulation syndrome in Parkinson\u2019s disease: from clinical and neuropsychological characterisation to management and long-term outcome","volume":"85","author":"Cilia R","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"ref59","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/jnnp-2017-315985","article-title":"Dopamine dysregulation syndrome in Parkinson\u2019s disease: a systematic review of published cases","volume":"88","author":"Warren N","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"14","key":"ref60","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/mds.25636","article-title":"Levodopa infusion improves impulsivity and dopamine dysregulation syndrome in Parkinson\u2019s disease","volume":"28","author":"Catal\u00e1n MJ","year":"2013","journal-title":"Mov Disord"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v76n6\/0004-282X-anp-76-6-0399.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T09:22:17Z","timestamp":1604568137000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2018000600399&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":60,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["S0004-282X2018000600399"],"URL":"https:\/\/doi.org\/10.1590\/0004-282x20180052","relation":{},"ISSN":["1678-4227","0004-282X"],"issn-type":[{"value":"1678-4227","type":"electronic"},{"value":"0004-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}